Patent US7029913B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US7029913B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Primate embryonic stem cells

Assignee: Wisconsin Alumni Research Foundation
•
Filing: 2001-10-18
•
Granted: 2006-04-18
•
Expires: 2021-10-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A purified preparation of primate embryonic stem cells is disclosed. This preparation is characterized by the following cell surface markers: SSEA-1 (−); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); and alkaline phosphatase (+). In a particularly advantageous embodiment, the cells of the preparation are human embryonic stem cells, have normal karyotypes, and continue to proliferate in an undifferentiated state after continuous culture for eleven months. The embryonic stem cell lines also retain the ability, throughout the culture, to form trophoblast and to differentiate into all tissues derived from all three embryonic germ layers (endoderm, mesoderm and ectoderm). A method for isolating a primate embryonic stem cell line is also disclosed.

Inventors

  • 👤 James A. Thomson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 23:16
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0603; C12N5/0605; A; A61; A61P; A61P25/00; A61P25/14; A61P25/16; A61P3/00; A61P3/08; A61P3/10; A61P37/00; C12N5/0606; C12N2502/00; C12N2502/13; C12N2506/00; C12N2506/02

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 78 words
A replicating in vitro cell culture of human embryonic stem cells comprising cells which (i) are capable of proliferation in in vitro culture for over one year without the application of exogenous leukemia inhibitory factor, (ii) maintain a karyotype in which the chromosomes are euploid through prolonged culture, (iii) maintain the potential to differentiate to derivatives of endoderm, mesoderm, and ectoderm tissues throughout the culture, and (iv) are inhibited from differentiation when cultured on a fibroblast feeder layer.
Claim 2
Dependent Claim 78 words
A replicating in vitro cell culture of human embryonic stem cells comprising cells which (i) are capable of proliferation in in vitro culture for over one year without the application of exogenous leukemia inhibitory factor, (ii) maintain a karyotype in which the chromosomes are euploid through prolonged culture, (iii) maintain the potential to differentiate to derivatives of endoderm, mesoderm, and ectoderm tissues throughout the culture, and (iv) are inhibited from differentiation when cultured on a fibroblast feeder layer.
Claim 3
Dependent Claim 24 words
The preparation of claim 1 , wherein the stem cells will spontaneously differentiate to trophoblast and produce chorionic gonadotropin when cultured to high density.
Claim 4
Dependent Claim 23 words
The preparation of claim 1 wherein the cells are negative for the SSEA-1 marker, positive for the SSEA-4 marker, and express alkaline phosphatase.

References Cited (Backward Citations)

US5541081A Cited
US5843780A Cited
US6200806B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2009-04-17 2009-10-17 2010-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2013-04-17 2013-10-17 2014-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2017-04-17 2017-10-17 2018-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag